UPDATE
: Monday, September 7, 2020
Home
Login
Mobile Version
All
Hospital
Pharma
Bio
Korea‘s Bio Industry
Device/ICT
Policy
People
Life science
Special
Innovation for Survival
Korea’s medical culture series
Korea’s New Candidate Drug Watch List
Special Series in Celebration of KBR's 1st Anniversary
Interview with foreign envoys
Special Series in Celebration of KBR’s 2nd Anniversary
Interview with global pharma
Special Series in Celebration of KBR’s 3rd Anniversary
Special Series in Celebration of KBR’s 4th Anniversary
ASCO 2020 Highlights
Opinion
Reporter’s Notebook
Search
트위터
페이스북
RSS
상단여백
제목보기
제목보기
제목+내용
Seoul OKs special import of remdesivir as Covid-19 treatment
by Kim Yun-mi
2020-06-03 16:05
Treating helicobacter bacteria after gastric cancer surgery lifts survival rate
by Lee Han-soo
2020-06-03 16:05
Korea confirms Covid-19 candidate drug’s effect through weasels
by Kwak Sung-sun
2020-06-03 16:05
‘KOEDC to broaden drug accessibility for patients with rare diseases’
by Kim Yun-mi
2020-06-03 12:37
Unrelenting church-linked infections raise worries about new viral wave
by Shim Hyun-tai
2020-06-03 12:34
라인
‘Mental, behavioral disorders’ social costs larger than their medical expense’
by Shim Hyun-tai
2020-06-02 18:28
[ASCO 2020 ③] Genexine’s combo therapy for breast cancer proves safety
by Shim Hyun-tai
2020-06-02 17:14
CDK 4/6 inhibitor market to heat up on insurance benefits
by Lee Han-soo
2020-06-02 17:13
‘54% of MERS survivors had mental illness even 1 year after recovery’
by Choi Gwang-seok
2020-06-02 15:38
‘Covid-19 heroes? Nurses worry about pay cuts’
by Song Soo-youn
2020-06-02 15:33
라인
Resurge of church-linked virus cases dims outlook for broader school reopening
by Shim Hyun-tai
2020-06-02 14:45
‘Keytruda doubled survival in advanced colon cancer compared to chemo’
by Kim Yun-mi
2020-06-02 11:27
[ASCO 2020 ②] GC confirms safety, efficacy of anti-EGFR monoclonal antibody
by Lee Han-soo
2020-06-02 11:20
[ASCO 2020 ①] Samsung Bioepis’ anticancer biosimilar shows equal quality to original drug
by Lee Han-soo
2020-06-01 16:14
‘Medical research should aim commercial use, not paper publishing’
by Kwak Sung-sun
2020-06-01 16:13
라인
Huons to supply emergency drugs to global market
by Shim Hyun-tai
2020-06-01 15:26
‘Etanercept may have delayed loss of smell in Covid-19 patient’
by Kim Eun-young
2020-06-01 15:12
'Lazertinib showed effect on lung cancer, brain metastasis'
by Park Gi-taek
2020-06-01 14:08
Korea wrestles with sporadic cluster infections, out-of-route spreads
by Shim Hyun-tai
2020-06-01 13:09
Wells Bio’s Covid-19 diagnostic kit wins urgent use permit
by Lee Han-soo
2020-06-01 11:24
-
이전
21
22
23
24
25
26
27
28
29
30
다음
-
176 civic groups furious over government-doctors deal
Amgen Korea wins new indication for acute lymphoblastic leukemia drug
UBcare wins patent for tech to monitor suspected infectious diseases
SCM Lifescience punished for delaying adverse reaction report
176 civic groups furious over government-doctors deal
Amgen Korea wins new indication for acute lymphoblastic leukemia drug
UBcare wins patent for tech to monitor suspected infectious diseases
SCM Lifescience punished for delaying adverse reaction report
여백
Most viewed
1
‘Cyramza helped improve gastric cancer treatment in Korea’
2
‘Reduced-dose prasugrel effective for ACS patients undergoing PCI’
3
Amgen Korea wins new indication for acute lymphoblastic leukemia drug
4
SNUBH develops AI model predicting patients at risk of cerebral aneurysm
5
Novavax releases encouraging phase-1 results on Covid-19 vaccine candidate
6
LG Chem, SK Bioscience end sales partnership with Daewoong
7
UBcare wins patent for tech to monitor suspected infectious diseases
8
176 civic groups furious over government-doctors deal
9
Recovered Covid-19 patients suffer from aftereffects – for long
10
Regulator OKs JW Pharma's rheumarthritis drug for treating giant cell arteries
여백
Opinion
[Column] Correct diagnosis leads to proper treatment
[Column] How ongoing doctors’ strike is different from 20 years ago
A Korean-American Doctor asks: Is Korea truly in 2020?
여백
Back to Top